SCHEMBL30359488

SCHEMBL30359488

[2H]c1ccc2ncc(C)n2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.39
TGFBR1 P36897 1/20 0.36
FLT3 P36888 3/20 0.34
CDK8 P49336 2/20 0.33
ROCK1 Q13464 2/20 0.33
DYRK1A Q13627 2/20 0.33
CHEK1 O14757 1/20 0.33
MAP4K4 O95819 1/20 0.33
CSF1R P07333 1/20 0.33
PRKACA P17612 1/20 0.33
KDR P35968 1/20 0.33
MAP2K1 Q02750 1/20 0.33
ACVR1 Q04771 1/20 0.33
MAP4K2 Q12851 1/20 0.33
AURKB Q96GD4 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
FLT1 P17948 1/20 0.33
CDK9 P50750 1/20 0.33
LIMK1 P53667 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84864 0.82 NPSR1 (0.50) NPSR1TGFBR1FLT3DYRK1ACHEK1
SCHEMBL30218031 0.77 NPSR1 (0.39) NPSR1FLT3CDK8ROCK1DYRK1A
Dimethylamine SCHEMBL7859896 0.77 NPSR1 (0.46) NPSR1TGFBR1FLT3DYRK1ANPC1
SCHEMBL17102638 0.68 NPC1 (0.41) NPSR1FLT3CDK8ROCK1DYRK1A
SCHEMBL7922826 0.68 KDM4E (0.54) FLT3NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL10238918 0.65 CYP1A2 (0.56) TGFBR1NPC1RAB9AHPGDSMN1; SMN2
SCHEMBL260258 0.65 CDK8 (0.56) CDK8ROCK1DYRK1ACHEK1MAP4K4
SCHEMBL3151800 0.65 BRAF (0.37) HPGDALDH1A1TP53MAPTPKM
SCHEMBL15233358 0.65 ADORA3 (0.52) NPSR1FLT3CDK8ROCK1DYRK1A
SCHEMBL20049424 0.65 KDM4E (0.41) FLT3KDRNPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747255-A1 MODULATORS OF THE ADENOSINE A2A AND A2B RECEPTOR Ryvu Therapeutics S.A. (PL) 2026-05-27 EP disclosed
WO-2025018901-A1 MODULATORS OF THE ADENOSINE A2A AND A2B RECEPTOR Ryvu Therapeutics S.A. (PL) 2025-01-23 WO disclosed
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 EP disclosed
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 WO disclosed